Senti Biosciences Inc (SNTI) — Financial Flexibility Index
Senti Biosciences Inc (SNTI) has a Financial Flexibility Index of -0.21x as of September 2025. Free cash flow of $-9.45 Million (operating CF $-9.45 Million minus capex $0.00) represents 0% of total liabilities ($44.56 Million). Check SNTI PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Senti Biosciences Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Senti Biosciences Inc across 6 annual periods. See Senti Biosciences Inc (SNTI) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Senti Biosciences Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Senti Biosciences Inc. For the full company profile including market capitalisation, see Senti Biosciences Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.57x | $-41.37 Million | $-41.40 Million | $72.19 Million | ▲ +25.3% |
| 2023 | -0.77x | $-40.36 Million | $-52.40 Million | $52.57 Million | ▼ -734.3% |
| 2022 | 0.12x | $6.48 Million | $-34.90 Million | $53.53 Million | ▲ +115.1% |
| 2021 | -0.80x | $-29.09 Million | $-34.63 Million | $36.33 Million | ▼ -272.6% |
| 2020 | -0.21x | $-23.01 Million | $-24.17 Million | $107.06 Million | ▲ +76.5% |
| 2019 | -0.92x | $-16.38 Million | $-18.38 Million | $17.88 Million | — |